← Back to Search

Digital Hypertension Management System

Digital Hypertension Management for High Blood Pressure (HrtEx Trial)

N/A
Recruiting
Led By Paul J Wang, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≤ 2 current anti-HTN meds
Age 30-90 yrs.
Must not have
Heart failure with reduced ejection fraction (EF < 40%)
Prior solid organ transplantation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1 (baseline), visit-3 (6 month follow up)
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two treatments to see which is more effective. Results are analyzed from two groups of people.

Who is the study for?
This trial is for adults aged 30-90 with high blood pressure who own a smartphone and are currently on no more than two blood pressure medications. They must be able to increase the dosage or add at least two types of certain blood pressure drugs, and speak English or Spanish. People can't join if they're pregnant, have specific heart or kidney conditions, recently had a heart attack or stroke, were hospitalized for severe hypertension, or had an organ transplant.
What is being tested?
The study compares a digital system that helps manage high blood pressure against the usual care methods. Participants will be randomly assigned to one of these two groups in this parallel-design trial to see which is more effective at controlling their condition.
What are the potential side effects?
Since this trial involves standard hypertension treatments compared with digital management tools rather than new medications, side effects may not apply as typically seen in drug trials but could include issues related to medication adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am taking 2 or fewer medications for high blood pressure.
Select...
I am between 30 and 90 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My heart's pumping ability is significantly reduced.
Select...
I have had a solid organ transplant.
Select...
I am on dialysis.
Select...
My kidneys are failing (GFR <15).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit-1 (baseline), visit-3 (6 month follow up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit-1 (baseline), visit-3 (6 month follow up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Defined Daily Dose (DDD)
Secondary study objectives
Antihypertensive Drugs
Clinician inertia
Diastolic blood pressure (DBP)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Health TechnologyExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,519,012 Total Patients Enrolled
Santa Clara Valley Medical CenterOTHER
16 Previous Clinical Trials
2,190 Total Patients Enrolled
The Cooper Health SystemOTHER
81 Previous Clinical Trials
35,427 Total Patients Enrolled
Paul J Wang, MDPrincipal InvestigatorStanford University
2 Previous Clinical Trials
1,002 Total Patients Enrolled

Media Library

Digital Hypertension Management System (Digital Hypertension Management System) Clinical Trial Eligibility Overview. Trial Name: NCT05479461 — N/A
High Blood Pressure Research Study Groups: Mobile Health Technology, Usual Care
High Blood Pressure Clinical Trial 2023: Digital Hypertension Management System Highlights & Side Effects. Trial Name: NCT05479461 — N/A
Digital Hypertension Management System (Digital Hypertension Management System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05479461 — N/A
~19 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top